At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis
In Brief
A Phase 4 clinical trial evaluating 68Ga-DOTATATE PET/CT, 18FDG PET/CT scan, and 1 other intervention for Cardiac Sarcoidosis. Completed, enrolled 15 participants across 1 site.
Detailed Summary
The Researchers are trying to determine if 68Ga-DOTATATE PET/CT imaging will have a similar accuracy as 18FDG PET/CT in diagnosing cardiac sarcoidosis and if it will be able to do so without the need for complex patient dietary preparation that is required with 18FDG PET/CT.
Study Details
Timeline
Interventions
5.4 mCi of 68Ga-DOTATATE will be administered by intravenous route.
This scan will be performed as part of the planned clinical care for the patient. Dose of 18FDG will be administered intravenously in accordance with the institutional policy and accepted norms. CT attenuation scan will also be performed as part of this examination per institutional protocol.
This scan will be performed as part of the planned clinical care for the patient. Dose of 13NH3 will be administered intravenously in accordance with the institutional policy and accepted norms. CT attenuation scan will also be performed as part of this examination per institutional protocol.